Free Trial

British American Tobacco (Baa1 Stable now/BBB+/BBB+) Moody's Upgrade follow up

CONSUMER STAPLES

Upgrade is backward looking driven by the co's lower net leverage target of 2-2.5x (from original 2-3x) which it introduced in March. Moody's adjusted gross leverage is circa +0.5x over co's reported net for reference.

  • Its flagging the US combustibles weakness - which we also noted on Altria's miss. Reminder Altria is pure-play US and unlike PM and JAPTOB, is still heavily combustibles. It's also noting the pressure in US vapes from sale of illicits - a common complaint from both Altria and BAT.
  • It sees EBITDA falling 5% this year before rising LSD in the next two years. Upgrades are limited even on continued deleveraging; it wants to see more non-combustibles exposure make up sales (where the growth is). Consensus is looking for a -2.3% EBITDA fall before a similar LSD rise.

We will need to circle back on RV but we've generally been confused by BAT trading in line with Altria and Imperial - former lacks geographical diversification, latter is the lowest in the sector for non-combustibles exposure. A harsh 35-40bp pickup also there for rotations out of JAPTOB/PM into BAT between the 3-5yr - but that spread is still inside historical levels.

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.